ElasticECG: roll-to-roll (R2R) manufactured, stretchable, ultra-low power ECG...
ElasticECG: roll-to-roll (R2R) manufactured, stretchable, ultra-low power ECG skin sensor.
Source: VTT

virtual.COMPAMED receives international resonance

For the first time in the history of COMPAMED, the number one platform for the suppliers of the medical technology industry took place entirely online due to the pandemic - but still won over their audiences due to their high degree of international resonance in this format too.

Innovations that can help overcome the pandemic quickly were the centre of attention at virtual.COMPAMED (215 exhibitors) for the supplier market for medical manufacturing. Many companies from the microtechnology sectors are active here, and have banded together under the IVAM Association for Microtechnology. The association organised the English High-Tech Forum in the Conference Area. Microfluidics is a core technology here, with respect to advancing reliable and economic rapid tests and point-of-care diagnostics. 

Microfluidic systems have many advantages, notably including short analysis times, reduction of production costs and low consumption of samples and/or reagents. These are all points that play a huge role in fighting the pandemic. Automated analytic devices are thus a prerequisite for providing large testing capacities for the novel coronavirus. This automation increases test numbers significantly as it uses faster processes which are ran in parallel, saves on personnel and assures process reliability. 

Exhibitors at virtual.COMPAMED offered a broad spectrum of services for this - from contract processing and contract production for disposable microfluidic systems to development and manufacturing of fully automated sample preparation and molecular diagnostic systems.

Recommended article

An industry in revolution

Virtual.COMPAMED and virtual.MEDICA showed that the medical technology industry is working hand in hand with developers from the research and scientific sectors, at full innovative throttle, to go head-to-head against the challenging business trends. The extent to which the corona pandemic will change the industry, and to what extent a globally functioning (and virtual) platform is needed right now for exchanging and doing good business, is shown by the new trend report: “How SARS-CoV-2 Has Changed the Medical Technology Sector". This report was published by the German Industry Association Spectaris and Roland Berger (in conjunction with the medical technology cluster MedicalMountains) within the scope of virtual.MEDICA 2020. 

Regardless of current business conditions and a drop in turnover due to the crisis, experts expect radical changes to occur within the market and in terms of competition in both the middle and long term. “The crisis set an irreversible chain of events into motion. Digital working models and sales, service and exhibition concepts have now taken on a prized position in many companies’ strategies, and will continue to be prioritised at least at the same level as classic working methods and personal customer contacts, even after the corona pandemic”, explains Jörg Mayer, Executive Director of Spectaris.

All Glass Microfluidic Flow Cells with integrated nanopatterning enabling...
All Glass Microfluidic Flow Cells with integrated nanopatterning enabling High-thoughput Multiplex As-says and Next Genneration Sequencing.
Source: IMT Masken und Teilungen AG

Hybrid concept for 2021

Dr. Thomas Dietrich, Executive Director of the IVAM, is turning his attention to the coming year: “I think it’s very sensible to encourage more virtual meetings during the corona pandemic. However, meeting in person at trade fairs and conferences remains essential for creating long-term business relationships that are built on trust, and this is simply irreplaceable. This is why we’re already looking forward to seeing our customers again in person at COMPAMED 2021 in Düsseldorf.”

The majority of the speeches at virtual.Compamed, along with the accompanying virtual congresses and conferences will remain available to registered users for viewing online until the end of May 2021. The exhibitors’ online showrooms will also be accessible up until then.

COMPAMED 2021 will be held from 15 - 18 November 2021 as a hybrid event. The hybrid concept consists of combining live platforms for professional visitors to the Düsseldorf trade fair centre and digital offers.

Information is available online at https://www.compamed-tradefair.com.

Subscribe to our newsletter

Related articles

virtual.COMPAMED 2020 highlights the importance of suppliers

virtual.COMPAMED 2020 highlights the importance of suppliers

The supplier sector will showcase its expertise and innovative high-tech solutions for the medical technology industry.

COVID-19 speeds up microfluidics development

COVID-19 speeds up microfluidics development

With soaring demand for point-of-care testing (POCT), microfluidics has been a pivotal resource as COVID-19 swept across the world.

Face mask detects Covid-19 infection

Face mask detects Covid-19 infection

Engineers have designed a novel face mask that can diagnose the wearer with Covid-19 within about 90 minutes.

Microfluidic chip simplifies COVID-19 testing

Microfluidic chip simplifies COVID-19 testing

COVID-19 can be diagnosed in 55 minutes or less with the help of programmed magnetic nanobeads and a diagnostic tool that plugs into an off-the-shelf cellphone.

Sensor rapidly detects multiple sepsis biomarkers

Sensor rapidly detects multiple sepsis biomarkers

The Wyss Institute's eRapid electrochemical sensor technology now enables specific and multiplexed detection of blood biomarkers at low cost.

Biosensor detects COVID-19 antibodies in seconds

Biosensor detects COVID-19 antibodies in seconds

An advanced nanomaterial-based biosensing platform detects antibodies specific to SARS-CoV-2 within seconds.

Device achieves unprecedented control of cell membrane voltage

Device achieves unprecedented control of cell membrane voltage

Scientists have developed a bioelectronic system driven by a machine learning algorithm that can shift the membrane voltage in living cells and maintain it at a set point for 10 hours.

A microfluidic chip system as alternative to animal experiments

A microfluidic chip system as alternative to animal experiments

Since mid-2019, the Fraunhofer IBMT has been developing an analysis platform as an alternative to animal experiments in drug development.

Fabricated corneal tissue allows closer look at how eyes heal

Fabricated corneal tissue allows closer look at how eyes heal

Researchers used a microfluidic devices to fabricate tiny strands of collagen called fibrils to help further his team’s research on the eye’s repair process.

Popular articles

Subscribe to Newsletter